Prazosin for Veterans with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence: A Clinical Trial
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background: Posttraumatic stress disorder (PTSD) is an important and timely clinical issue particularly for combat veterans. Few pharmacologic options are available to treat PTSD, particularly among military personnel, and they are not based on rational neurobiology. The evidence for noradrenergic dysregulation in PTSD is strong, and the alpha‐adrenergic agonist prazosin is one of the most promising medications to treat sleep disturbances associated with PTSD as well as PTSD symptoms among both veterans and civilians. Evidence also implicates noradrenergic dysregulation in the pathophysiology of alcohol dependence (AD); prazosin also may have efficacy in treating this disorder. The use of prazosin represents a rational and compelling approach for the treatment of PTSD and comorbid AD. Given the high rates of comorbid AD in trauma survivors with PTSD, and the enormous impact that these comorbid disorders have on psychosocial function and well‐being, finding effective treatments for this population is of high clinical importance. Methods: Ninety‐six veterans with PTSD and comorbid AD were randomized to receive prazosin (16 mg) or placebo in an outpatient, randomized, double‐blind, clinical trial for 13 weeks. Main outcomes included symptoms of PTSD, sleep disturbances, and alcohol use. Results: Symptoms of PTSD improved over time, but contrary to the hypothesis, there was no medication effect on PTSD symptoms, or on sleep. Alcohol consumption also decreased over time, but there were no significant differences in outcomes between medication groups. Conclusions: Prazosin was not effective in treating PTSD symptoms, improving sleep, or reducing alcohol consumption overall in this dually diagnosed group. This does not support the use of prazosin in an actively drinking population and suggests that the presence of a comorbid condition affects the efficacy of this medication. This study highlights the importance of conducting clinical trials in “real‐world” patients, as results may vary based on comorbid conditions.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Combat Duty in Iraq and Afghanistan, Mental Health Problems, and Barriers to Care
Hoge, C. W., Castro, C. A., Messer, S. C., McGurk, D., Cotting, D. I., & Koffman, R. L. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa040603 · Cited by 4,778
Sobell, L. C., & Sobell, M. B. (1992) · Measuring Alcohol Consumption · doi:10.1007/978-1-4612-0357-5_3 · Cited by 4,110
Milliken, C. S., Auchterlonie, J. L., & Hoge, C. W. (2007) · JAMA · doi:10.1001/jama.298.18.2141 · Cited by 1,640 · cited 1×
“The risk of developing PTSD among combat-exposed military personnel is very high (Hoge et al., 2006), and screenings of soldiers returning from the recent conflicts in Iraq and Afghanistan have found rates of PTSD up to 24.5% (Hoge et al., 2004, 2006, 2007; Milliken et al., 2007).”
BackgroundInfluentialRole of norepinephrine in the pathophysiology and treatment of posttraumatic stress disorder
Southwick, S. M., Bremner, J. D., Rasmusson, A., Morgan, C. A., Arnsten, A., & Charney, D. S. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(99)00219-x · Cited by 573 · cited 1×
“The noradrenergic system is thought to play an integral role in the development and maintenance of PTSD (Southwick et al., 1999).”
BackgroundSelf-citationArnsten, A. F. T., Raskind, M. A., Taylor, F. B., & Connor, D. F. (2015) · Neurobiology of Stress · doi:10.1016/j.ynstr.2014.10.002 · Cited by 381
McCormick, D. A., Pape, H.-C., & Williamson, A. (1991) · Progress in Brain Research · doi:10.1016/s0079-6123(08)63817-0 · Cited by 209 · cited 2×
“Preclinical data predicts alpha-1 blockade in the locus coeruleus (Aston-Jones et al., 1994), amygdala (Nader and LeDoux, 1999), thalamus (McCormick et al., 1991), and prefrontal cortex (Arnsten et al., 2015) would help to preserve prefrontal cortical function and reduce hypervigilance, insomnia,…”
Background
Cited by
Substance use disorders in military veterans: prevalence and treatment challenges
Teeters, J., Lancaster, C., Brown, D., & Back, S. (2017) · Substance Abuse and Rehabilitation · doi:10.2147/sar.s116720 · Cited by 290
Krystal, J. H., Davis, L. L., Neylan, T. C., A. Raskind, M., Schnurr, P. P., Stein, M. B., Vessicchio, J., Shiner, B., Gleason, T. D., & Huang, G. D. (2017) · Biological Psychiatry · doi:10.1016/j.biopsych.2017.03.007 · Cited by 265
“Completed (10/2014) Department of Defense and VA VISN 1 Negative (59)”
BackgroundResultTrauma associated sleep disorder: a parasomnia induced by trauma
Mysliwiec, V., Brock, M. S., Creamer, J. L., O'Reilly, B. M., Germain, A., & Roth, B. J. (2018) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2017.01.004 · Cited by 150
Hoskins, M. D., Bridges, J., Sinnerton, R., Nakamura, A., Underwood, J. F. G., Slater, A., Lee, M. R. D., Clarke, L., Lewis, C., Roberts, N. P., et al. (2021) · European Journal of Psychotraumatology · doi:10.1080/20008198.2020.1802920 · Cited by 127
“…et al., 2011; Lindley et al., 2007; Ludascher et al., 2015; Manteghi et al., 2014; Monnelly et al., 2003; Naylor et al., 2015; Neylan et al., 2006; Petrakis et al., 2016; Pollack et al., 2011; Ramaswamy et al., 2016; Raskind et al., 2018, 2007, 2003, 2013; Reich et al., 2004; Rothbaum et al.,…”
BackgroundInfluentialNoradrenergic targets for the treatment of alcohol use disorder
Haass-Koffler, C. L., Swift, R. M., & Leggio, L. (2018) · Psychopharmacology · doi:10.1007/s00213-018-4843-6 · Cited by 117
Hien, D. A., Morgan-López, A. A., Saavedra, L. M., Ruglass, L. M., Ye, A., López-Castro, T., Fitzpatrick, S., Killeen, T. K., Norman, S. B., Ebrahimi, C. T., et al. (2023) · American Journal of Psychiatry · doi:10.1176/appi.ajp.22010071 · Cited by 99
Bajor, L. A., Balsara, C., & Osser, D. N. (2022) · Psychiatry Research · doi:10.1016/j.psychres.2022.114840 · Cited by 43
Vanderkam, P., Solinas, M., Ingrand, I., Doux, N., Ebrahimighavam, S., Jaafari, N., & Lafay‐Chebassier, C. (2021) · Addiction · doi:10.1111/add.15265 · Cited by 25
Metadata
- Authors
- Petrakis, I. L., Desai, N., Gueorguieva, R., Arias, A., O'Brien, E., Jane, J. S., Sevarino, K., Southwick, S., & Ralevski, E.
- Venue
- Alcoholism: Clinical and Experimental Research
- Publisher
- Wiley
- Published
- 2015-12-19
- Volume
- 40
- Issue
- 1
- Pages
- 178-186
- ISSN
- 0145-6008 (ISSN-L)
- 1530-0277
- OpenAlex
- W2206866143
- Cited by
- 115
- References
- 6
- FWCI
- 13.96
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.